Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2007
05/09/2007CN1314398C Cream for treating dexmatosis, and its prepn. method
05/09/2007CN1314397C Effective site extract of lotus plumule and its usage
05/09/2007CN1314396C Application of levoornidazole in preparation of anti anaerobic bacteria infection medicine
05/09/2007CN1314395C Medicine for treating acne and preparation thereof
05/09/2007CN1314394C Pharmaceutical composition containing double nucleus platinum complex and its application in anti-tumour
05/09/2007CN1314393C Method for treating hair-dropping using thyromimetic compound
05/09/2007CN1314392C Local anesthesia fusion spray cloth for human body local anesthesia and preparing method
05/09/2007CN1314391C Baofukang vagina effervescent tablet and its making method
05/09/2007CN1314390C Pharmaceutical dosage form with multiple coatings
05/09/2007CN1314361C Joint healthy beverage or food and preparation thereof
05/09/2007CN1314357C Acidic compositions comprising protein and fiber and processes of their preparation
05/08/2007USRE39616 Aminoindan derivatives
05/08/2007USRE39614 Canine IL-4 immunoregulatory proteins and uses thereof
05/08/2007US7216041 Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket
05/08/2007US7214826 N-methyl-3-hydroxy-4,4-dimethyl-2-(2'naphthyl)pentylamine; potent, wide-spectrum antidepressant and treating anxiety disorders
05/08/2007US7214823 Forming hydroxycitric acid salts with metals such as potassium, calcium, sodium, zinc and magnesium with extraction of solutions
05/08/2007US7214805 Process for the industrial synthesis of strontium ranelate and its hydrates
05/08/2007US7214804 Heterocyclic compounds useful as growth hormone secretagogues
05/08/2007US7214802 Anti-cytokine heterocyclic compounds
05/08/2007US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
05/08/2007US7214799 Protecting the hydroxyls of 3-hydroxy-4,5-dimethylol-2-picoline, reacting the 4-methylol group with an imide (especially potasssium phthalimide), cleaving the imide group to deprotect the amine group, and deprotecting the remaining hydroxy groups
05/08/2007US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics
05/08/2007US7214794 Capable of crossing cell membrane; induction apoptosis in human cancer cells
05/08/2007US7214791 Oxidizing and fluorinating the anhydroglucose to obtain 2-deoxy-2,2-difluoro-D-ribofuranose as intermediate; can be used in large-scale production
05/08/2007US7214790 Genes and proteins encoded thereby
05/08/2007US7214716 Hypotensive agents; antiinflammatory agents; gastrointestinal disorders; autoimmune disease; 4-phenyl pinene derivatives
05/08/2007US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
05/08/2007US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases
05/08/2007US7214713 Supplement with anticancer properties with fermentation of carbohydrates with biosynthesis of Penicillum
05/08/2007US7214712 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
05/08/2007US7214711 Method of treating migraine headache without aura
05/08/2007US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
05/08/2007US7214709 Taste; stomach sensitivity; side effect reduction
05/08/2007US7214708 potent inhibitor of tumor cell growth, acting via a microtubule stabilization mechanism; for treating a hyperproliferative disease
05/08/2007US7214707 Dimeric compounds and their use as anti-viral agents
05/08/2007US7214706 Osteoporosis, postmenopause
05/08/2007US7214705 Antiproliferative activity and is most unlikely a substrate for P-glycoprotein and/or Multidrug Resistant Protein
05/08/2007US7214704 For therapy of diabetes and related conditions
05/08/2007US7214703 Compounds for modulators of chemokine activity
05/08/2007US7214702 Reacting the amide compound with phosphorus oxychloride in an organic solvent; treating the reaction mixture with water to form (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-1-oxoethyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile-hydrochloride
05/08/2007US7214700 Administering to a human patient an 2-oxindole-3-ylidenyl) acetic acid derivatives which modulate the activity of protein kinases and effective to treat disorders related to abnormal protein kinase activity, such as cancer
05/08/2007US7214699 Indazole derivatives as CRF antagonists
05/08/2007US7214698 Beta-agonists, processes for preparing them and their use as pharmaceutical compositions
05/08/2007US7214697 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists
05/08/2007US7214696 Administering compounds such as -Carboxy-2-(3,5-difluorophenyl)-benzoxazole for therapy of transthyretin amyloid disease
05/08/2007US7214695 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
05/08/2007US7214694 Controlling transforming growth facor; artificial skin; wound healing agents
05/08/2007US7214693 Contraceptices; hormone sensitivity diseases; antidepressants; sexual disorders ; osteoporosis; alopecia
05/08/2007US7214692 Medical use for tachykinin antagonists
05/08/2007US7214691 For therapy of metabolic and eating disorders
05/08/2007US7214690 For therapy of acne, male- pattern baldness, sexual dysfunction, impotence, wasting diseases, hirsutism, hypogonadism, prostatic hyperplasia, osteoporosis, cancer cachexia, and hormone-dependent cancers
05/08/2007US7214689 Isoquinoline compounds
05/08/2007US7214688 Compounds
05/08/2007US7214687 Quinuclidine derivatives and medicinal compositions containing the same
05/08/2007US7214686 adjust release of neurotransmitters; Parkinson's disease; tourette Syndrome; attention deficit disorders; schizophrenia
05/08/2007US7214685 Antibody directed enzyme prodrug therapy
05/08/2007US7214684 Administering to a human a therapeutically effective amount of descarboethoxyloratadine
05/08/2007US7214683 Compositions of descarboethoxyloratadine
05/08/2007US7214682 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives
05/08/2007US7214681 Tri(cyclo) substituted amide compounds
05/08/2007US7214680 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
05/08/2007US7214679 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease;
05/08/2007US7214678 Having antiinflammatory, anti-pyretic and anti-diarrheal properties
05/08/2007US7214677 Benzamide, heteroarylamide and reverse amides
05/08/2007US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
05/08/2007US7214675 Administering the compound N-{2-[2-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}morpholine-4-carboxamide inducing cytokine biosynthesis; Viricides; anticancer agents; immunology moderators
05/08/2007US7214674 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
05/08/2007US7214673 For therapy of psychosis and bipolar disorder
05/08/2007US7214672 Preventives/remedies for inflammatory airway diseases
05/08/2007US7214671 Administering -methylene-19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 for prophylaxis of osteoporosis
05/08/2007US7214670 Administering to a post menopausal woman an effective amount of 2-methylene -19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3
05/08/2007US7214669 Tetracycline derivatives and methods of use thereof
05/08/2007US7214668 Viricides; anticancer agents; liver disorders
05/08/2007US7214667 Drugs against articular failure
05/08/2007US7214666 When ingested by mammals, is capable of repairing and regenerating articular cartilage, resulting in relief from associated symptoms of articular cartilage degeneration
05/08/2007US7214665 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
05/08/2007US7214664 Amino acid ester derivatives of bioactive compounds, and di-, tri, and tetra-peptide ester derivatives of bioactive compounds, for therapy
05/08/2007US7214663 The prodrug of the invention is a modified form of a therapeutic agent and comprises a therapeutic agent, an oligopeptide of three amino acids, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by a
05/08/2007US7214662 Prevents the aggregation of LHRH antagonists in solutions; bioavailability
05/08/2007US7214518 For therapy of diseases of cell proliferation
05/08/2007US7214506 Method for treating onychomycosis
05/08/2007US7214500 Brush-like structured surface of poly(ethylene oxide) having elevated density
05/08/2007US7214499 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide
05/08/2007US7214395 Pharmaceutical and cosmetic composition against skin aging
05/08/2007US7214394 Isolating policosanols from a seed or grain processing stream or a vegetable oil processing stream
05/08/2007US7214393 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent
05/08/2007US7214390 topical or transdermal mixtures comprising methyl nicotinate, L-arginine, plant extracts and carriers, used as sex response intensifiers
05/08/2007US7214387 Antidiabetic agents
05/08/2007US7214384 Lipid-conjugated polyamide compounds
05/08/2007US7214373 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
05/08/2007US7214368 Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene
05/08/2007US7214366 Linking a sulfur compound directly to a terminal carbon of polyethyleneglycol, polyalkylene oxides or a polyvinyl alcohol; converting the sulfur to an active ethyl sulfone group having a reactive site located at the second carbon from the sulfone group; modifying biologically active molecules
05/08/2007US7214365 Hydrophilic ingredient such as biotin, carnitine and derivatives thereof, creatine and derivatives thereof, folic acid, pyridoxine, niacinamide, polyphenols, ascorbic acid, Hamamelis, Aloe, or panthenol containing as a photostabilizer a di(C 6-24 branched or unbranched alkyl) 2,6-naphthalenedicarboxylate
05/08/2007US7214364 Antibiotic for gramnegative bacteria; atomized dry powder
05/08/2007US7213312 Funerary container made of paper material, and assembly device employed therein
05/08/2007CA2552694A1 Kit comprising three independent compositions and methods for building muscle, increasing strength, increasing muscle size, increasing muscle performance and reducing muscle fatigue
05/08/2007CA2545658A1 Compositions and methods for weight-loss and weight-loss maintenance in daytime and nighttime formulation
05/08/2007CA2443216C Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
05/08/2007CA2441804C Use of thiazole derivatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease
05/08/2007CA2432138C New process for the preparation of eletriptan
1 ... 3766 3767 3768 3769 3770 3771 3772 3773 3774 3775 3776 3777 3778 3779 3780 3781 3782 3783 3784 3785 3786 ... 7860